Discover if this is a suitable investor for your startup. If they are we'll make a warm introduction for free. Otherwise, we'll connect you with matching investors.
GrayBella Capital is a pan-European venture capital firm founded to invest in growth-stage technology-driven companies. Established with a mission to partner with founders in the HealthTech and DeepTech sectors, the firm emphasizes supporting innovative projects that have the potential to disrupt traditional industries. The firm operates with a clear alignment to the United Nations Sustainable Development Goals (SDGs), focusing on sustainable and impactful growth.
Currently, GrayBella Capital manages a diverse portfolio and has established itself as a key player in the European venture capital landscape. The firm typically invests between €3 million and €15 million in companies at Series A, B, and C stages. Their commitment to fostering growth in technology sectors is evident through their strategic investments and partnerships.
GrayBella Capital is headquartered in Europe, with a team that combines extensive experience in venture capital and industry expertise. The firm has made notable strides in the HealthTech and DeepTech sectors, contributing to advancements in technology and healthcare.
GrayBella Capital primarily invests in the HealthTech and DeepTech sectors, targeting companies that are at the forefront of technological innovation. In the HealthTech sector, the firm focuses on areas such as Diagnostics, Healthcare IT, Patient Monitoring, and Embedded Software. These focus areas reflect the firm’s commitment to enhancing healthcare delivery and patient outcomes through technology.
In the DeepTech sector, GrayBella Capital covers a wide range of advanced technologies, including IoT, Cloud Computing, SaaS Platforms, AI, Machine Learning, Data Science, Quantum Computing, and Nanotechnologies. The firm’s investment strategy typically involves providing growth capital investments ranging from €3 million to €15 million, which allows them to support companies at various stages of development. Their alignment with the United Nations Sustainable Development Goals underscores their commitment to investing in projects that not only promise financial returns but also contribute positively to society.
GrayBella Capital has built a notable portfolio of companies that exemplify its investment focus in HealthTech and DeepTech. Key portfolio companies include:
These companies represent GrayBella Capital's commitment to investing in innovative solutions that address critical challenges in healthcare and technology.
Richard P. Kivel: Managing Director with extensive experience in venture capital and a strong background in technology investments.
Ruta J. Laukien: Partner - US Operations, bringing expertise in cross-border investments and strategic partnerships.
Natalie Torin: Senior Adviser with a focus on market analysis and investment strategy.
Ruta Labalaukyte: Principal, specializing in deal sourcing and portfolio management.
Dr. Michael Rossbach: Venture Partner with a background in healthcare innovation and technology.
Diane Ibrahim: Operations Manager, overseeing the firm’s operational efficiency and support functions.
Dr. Geraldine A. Hamilton: Entrepreneur in Residence, providing mentorship and guidance to portfolio companies.
Marissa Fayer: Entrepreneur in Residence, focusing on strategic growth and market entry strategies.
Executive Advisors include:
Dr. Joseph Kvedar: Director at MGH / Harvard Center for Connected Health, offering insights into connected health technologies.
Kerry Halferty Hardy: Co-founder and advisor at Alcuin Advisors, with expertise in venture capital.
Wunibald Guertler: Managing his family office, supporting European venture capital firms.
John Brooks: Former CEO of Joslin Diabetes Center, providing healthcare industry expertise.
Vladas Lasas: Lithuanian entrepreneur and investor with a focus on technology ventures.
Dr. Heiner Dreismann: Former President and CEO of Roche Molecular Diagnostics, contributing extensive industry knowledge.
To pitch GrayBella Capital, founders should use the submission form available on their website. It is essential to include a clear overview of the business model, market opportunity, and how the startup aligns with the firm’s investment focus in HealthTech and DeepTech.
Founders should expect a response time that varies based on the volume of submissions, but clarity and thoroughness in the pitch can facilitate quicker engagement. Warm introductions are beneficial but not mandatory.
As of March 2023, GrayBella Capital continues to expand its portfolio in the HealthTech and DeepTech sectors, focusing on companies that align with its investment thesis. The firm has made significant investments in innovative startups that are poised for growth.
Recent activities include the addition of new portfolio companies that exemplify the firm’s commitment to supporting disruptive technologies. GrayBella Capital remains active in seeking out partnerships that align with its mission of sustainable and impactful growth.
What are GrayBella Capital's investment criteria?
GrayBella Capital primarily invests in growth-stage technology-driven companies within the HealthTech and DeepTech sectors. They look for innovative projects that have the potential to disrupt industries and align with the United Nations Sustainable Development Goals.
How can I apply or pitch to GrayBella Capital?
Founders interested in pitching to GrayBella Capital can submit their proposals through a submission form available on their website. Specific email addresses for direct contact are not provided.
What makes GrayBella Capital different from other venture capital firms?
GrayBella Capital distinguishes itself through its focus on sustainable and impactful growth, aligning its investments with the United Nations Sustainable Development Goals. The firm emphasizes partnerships with founders in sectors that are poised for disruption.
What is the geographic scope of GrayBella Capital's investments?
The firm focuses on investments across Europe, targeting growth-stage companies that operate within its specified sectors.
What is the typical check size for investments?
GrayBella Capital typically invests between €3 million and €15 million in its portfolio companies, providing substantial growth capital to support their development.
What type of post-investment involvement does GrayBella Capital have?
GrayBella Capital adds value to its portfolio companies by providing strategic guidance and facilitating industry connections to enhance growth and innovation.
All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.